158 related articles for article (PubMed ID: 26787610)
21. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
22. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
23. Prothrombotic Risk Factors and Preventive Strategies in Adolescent Venous Thromboembolism.
Srivaths L; Dietrich JE
Clin Appl Thromb Hemost; 2016 Sep; 22(6):512-9. PubMed ID: 26883917
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis.
Lussana F; Coppens M; Cattaneo M; Middeldorp S
Thromb Res; 2012 Jun; 129(6):673-80. PubMed ID: 22365492
[TBL] [Abstract][Full Text] [Related]
25. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
Le Sage S; McGee M; Emed JD
J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
27. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
28. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
Bryk-Wiązania AH; Minasyan M; Świątkowska-Stodulska R; Undas A; Hubalewska-Dydejczyk A; Webb SM; Valassi E; Gilis-Januszewska A
Front Endocrinol (Lausanne); 2024; 15():1350010. PubMed ID: 38529392
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?
Bryant RV; Jairath V; Curry N; Travis SP
J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288
[TBL] [Abstract][Full Text] [Related]
30. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
32. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
[TBL] [Abstract][Full Text] [Related]
33. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
[TBL] [Abstract][Full Text] [Related]
35. Venous Thromboembolism in Minimally Invasive Gynecologic Surgery: A Systematic Review.
Jorgensen EM; Hur HC
J Minim Invasive Gynecol; 2019 Feb; 26(2):186-196. PubMed ID: 30193970
[TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
[TBL] [Abstract][Full Text] [Related]
37. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
[TBL] [Abstract][Full Text] [Related]
38. The prevention of pregnancy-related venous thromboembolism.
Guimicheva B; Czuprynska J; Arya R
Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism prevention in patients undergoing colorectal surgery for cancer.
Holwell A; McKenzie JL; Holmes M; Woods R; Nandurkar H; Tam CS; Bazargan A
ANZ J Surg; 2014 Apr; 84(4):284-8. PubMed ID: 23782713
[TBL] [Abstract][Full Text] [Related]
40. Thromboprophylaxis in a pediatric hospital.
Sharma M; Carpenter SL
Curr Probl Pediatr Adolesc Health Care; 2013 Aug; 43(7):178-83. PubMed ID: 23890025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
